Open-to-Accrual Therapeutic Trials


Dr Ted Johnson in lab
Help us say Yes. It's time.

Protocol ID

Official Title

PI Name

Contact Person

Disease Site

Phase

 NLG-2105 
ClinicalTrials.gov: 
NCT02502708
 Phase 1 Trial
of Indoximod
in Combination
with Temozolomide-based Therapy for Children with Progressive
Primary Brain
Tumors
 T. Johnson Robin Dobbins
& 
Kimberly Gray
 Brain Tumor  I
 NMTRC014 
ClinicalTrials.gov: 
NCT02679144
NMTT -
Neuroblastoma Maintenance
Therapy Trial
Using Difluoromethylornithine (DFMO);
NMTRC014
 
 C. McDonough Kimberly Gray  Neuroblastoma  II
 
 

Contact Us

Georgia Cancer Center Pediatric Immunotherapy
Augusta University
Health Science Campus
Georgia Cancer Research Center

Robin Dobbins, RN
Senior Clinical Research Nurse
Office: 706-721-2154

Beth Fisher, RN, PNP
Immunotherapy Nurse-Practitioner
Office: 706-723-0000

Kimberly Gray
Research Manager
Office: 706-721-1870

Theodore S. Johnson, M.D., Ph.D.
Director, Clinical Pediatric Immunotherapy Service
Georgia Cancer Center
Office: 706-721-4962
Fax:     (706) 721-4804